Cargando…

Microbial Etiology of Pyogenic Vertebral Osteomyelitis According to Patient Characteristics

BACKGROUND: It is difficult to select an appropriate empirical antibiotic treatment regimen for patients with culture-negative pyogenic vertebral osteomyelitis (PVO). Having knowledge of the distribution of microorganisms according to patient characteristics can help clinicians make informed choices...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Dong Youn, Kim, Uh Jin, Yu, Yohan, Kim, Seong-Eun, Kang, Seung-Ji, Jun, Kang-Il, Kang, Chang Kyung, Song, Kyoung-Ho, Choe, Pyoeng Gyun, Kim, Eu Suk, Kim, Hong Bin, Jang, Hee-Chang, Jung, Sook In, Oh, Myoung-don, Park, Kyung-Hwa, Kim, Nam Joong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270706/ https://www.ncbi.nlm.nih.gov/pubmed/32523973 http://dx.doi.org/10.1093/ofid/ofaa176

Ejemplares similares

Clinical Characteristics and Risk Factors of Pyogenic Spondylitis Caused by Gram-Negative Bacteria
por: Kang, Seung-Ji, et al.
Publicado: (2015)

Limited Positive Predictive Value of β-d-Glucan in Hematologic Patients Receiving Antimold Prophylaxis
por: Chang, Euijin, et al.
Publicado: (2020)

Concordance of Results of Blood and Tissue Cultures from Patients with Pyogenic Spondylitis
por: Bae, Ji Yun, et al.
Publicado: (2017)

Treatment outcomes in patients with pyogenic vertebral osteomyelitis who have cirrhosis
por: Kim, Jihye, et al.
Publicado: (2019)

Different degree of cytokinemia and T-cell activation according to serum IL-6 levels in critical COVID-19
por: Lee, Chan Mi, et al.
Publicado: (2023)

Comparison of characteristics of culture-negative pyogenic spondylitis and tuberculous spondylitis: a retrospective study
por: Kim, Chung-Jong, et al.
Publicado: (2016)

How We Have Treated Severe to Critically Ill Patients With Coronavirus Disease 2019 in Korea
por: Park, Do Hyeon, et al.
Publicado: (2022)

Long-Term Outcome of Pyogenic Vertebral Osteomyelitis: A Cohort Study of 260 Patients
por: Gupta, Arjun, et al.
Publicado: (2014)

Kinetics of Neutralizing Antibody Responses Against SARS-CoV-2 Delta Variant in Patients Infected at the Beginning of the Pandemic
por: Choe, Pyoeng Gyun, et al.
Publicado: (2022)

A Direct Rapid Phenotypic Antimicrobial Susceptibility Test Enables Early Selection of Optimal Antibiotics to Treat Bacteremia in COVID-19 Patients
por: Park, Do Hyeon, et al.
Publicado: (2021)

813. The Reduction of the acquisition rate of carbapenem resistant Acinetobacter baumannii after room privatization in the intensive care unit
por: Jung, Jongtak, et al.
Publicado: (2020)

Minimizing contamination in the use of personal protective equipment: Simulation results through tracking contamination and enhanced protocols
por: Kang, JaHyun, et al.
Publicado: (2021)

Prolonged (6-Month) Shedding of Middle East Respiratory Syndrome Coronavirus RNA in the Sputum of a Lymphoma Patient
por: Choe, Pyoeng Gyun, et al.
Publicado: (2020)

Antimicrobial therapy and assessing therapeutic response in culture-negative pyogenic vertebral osteomyelitis: a retrospective comparative study with culture-positive pyogenic vertebral osteomyelitis
por: Yu, Dongwoo, et al.
Publicado: (2020)

Clinical Characteristics of Patients with Pyogenic Vertebral Osteomyelitis and Concurrent Infections and Their Clinical Outcomes
por: Kim, Donghyun, et al.
Publicado: (2022)

416. Poor clinical outcomes of COVID-19 patients receiving rituximab during the Omicron era
por: Lee, Chan Mi, et al.
Publicado: (2023)

Effect of Wearing Personal Protective Equipment (PPE) for COVID-19 Treatment on Blood Culture Contamination: Implication for Optimal PPE Strategies
por: Park, Jae Hyeon, et al.
Publicado: (2023)

Pyogenic Vertebral Osteomyelitis: Clinical Features, Diagnosis, and Treatment
por: Kwon, Ji-Woong, et al.
Publicado: (2017)

Epidemiology, Microbiological Diagnosis, and Clinical Outcomes in Pyogenic Vertebral Osteomyelitis: A 10-year Retrospective Cohort Study
por: Chong, Brian S W, et al.
Publicado: (2018)

Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients
por: Choe, Pyoeng Gyun, et al.
Publicado: (2020)

1097. Is Early Bisphosphonate Treatment Safe or Effective for Pyogenic Vertebral Osteomyelitis With Osteoporosis?
por: Kim, Jihye, et al.
Publicado: (2018)

1425. Treatment Outcomes in Patients with Pyogenic Vertebral Osteomyelitis Who Have Cirrhosis
por: Kim, Tae-Hwan, et al.
Publicado: (2019)

Clinical Impact of Empirical Antibiotic Therapy in Patients With Coronavirus Disease 2019 Requiring Oxygen Therapy
por: Park, Do Hyeon, et al.
Publicado: (2022)

Distinct Immune Response at 1 Year Post-COVID-19 According to Disease Severity
por: Kang, Chang Kyung, et al.
Publicado: (2022)

Corrigendum: Distinct Immune Response at 1 Year Post-COVID-19 According to Disease Severity
por: Kang, Chang Kyung, et al.
Publicado: (2022)

Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity
por: Kang, Chang Kyung, et al.
Publicado: (2020)

Sudden Deaths of Neonates Receiving Intravenous Infusion of Lipid Emulsion Contaminated with Citrobacter freundii
por: Bae, Ji Yun, et al.
Publicado: (2018)

1147. Short Course of Voriconazole Therapy as a Risk Factor for Relapse of Invasive Pulmonary Aspergillosis
por: Shin, Dong Hoon, et al.
Publicado: (2020)

Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection
por: Choe, Pyoeng Gyun, et al.
Publicado: (2021)

Antibody Responses One Year after Mild SARS-CoV-2 Infection
por: Choe, Pyoeng Gyun, et al.
Publicado: (2021)

Clinical Application of the Standard Q COVID-19 Ag Test for the Detection of SARS-CoV-2 Infection
por: Oh, Sang-Min, et al.
Publicado: (2021)

Work Restrictions for Healthcare Personnel with Potential In-hospital Exposure to SARS-CoV-2: Experience at a Tertiary Hospital
por: Jo, Hyeon Jae, et al.
Publicado: (2021)

Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection
por: Choe, Pyoeng Gyun, et al.
Publicado: (2021)

Short course of voriconazole therapy as a risk factor for relapse of invasive pulmonary aspergillosis
por: Shin, Dong Hoon, et al.
Publicado: (2020)

Recovery of Tenofovir-induced Nephrotoxicity following Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Human Immunodeficiency Virus-Positive Patients
por: Seo, Jun-Won, et al.
Publicado: (2020)

In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses
por: Kang, Chang Kyung, et al.
Publicado: (2020)

Evaluation of Seropositivity After Standard Doses of Vaccination Against SARS-CoV-2 in Patients With Early Breast Cancer Receiving Adjuvant Treatment
por: Kim, Jinyong, et al.
Publicado: (2022)

1426. Outcomes of Additional Instrumentation in Elderly Patients with Pyogenic Vertebral Osteomyelitis and Previous Spinal Instrumentation
por: Kim, Tae-Hwan, et al.
Publicado: (2019)

Oral Versus Standard Antimicrobial Treatment for Pyogenic Native Vertebral Osteomyelitis: A Single-Center, Retrospective, Propensity Score-Balanced Analysis
por: Marconi, Lorenzo, et al.
Publicado: (2022)

Clinical and Epidemiologic Characteristics of Spreaders of Middle East Respiratory Syndrome Coronavirus during the 2015 Outbreak in Korea
por: Kang, Chang Kyung, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8tmj8rh9na4sfrfi9l94ntojc3